Abstract:Although many genetic variants related to anti-tuberculosis drug induced liver injury (ATDILI) have been identified, the prediction and personalized treatment of ATDILI have failed to achieve, indicating there remains an area for further exploration. This study aimed to explore the influence of single nucleotide polymorphisms (SNPs) in Bradykinin receptor B2 (BDKRB2), Teneurin transmembrane protein 2 (TENM2), transforming growth factor beta 2 (TGFB2), and solute carrier family 2 member 13 (SLC2A13) on the risk of ATDILI. The subjects comprised 746 Chinese tuberculosis (TB) patients. Custom-by-design 2x48-Plex SNPscanTM kit was employed to genotype 28 selected SNPs. The associations of SNPs with ATDILI risk and clinical phenotypes were analyzed according to the distributions of allelic and genotypic frequencies and different genetic models. The odds ratio (OR) with corresponding 95% confidence interval (CI) was calculated. Among subjects with successfully genotyped, 107 participants suffered from ATDILI during follow-up. In BDKRB2, patients with rs79280755 G allele or rs117806152 C allele were more vulnerable to ATDILI (P-Bonferronicorrection=.002 and .03, respectively). Rs79280755 increased the risk of ATDILI significantly whether in additive (OR=3.218, 95% CI: 1.686-6.139, P-Bonferroni correction=.003) or dominant model (P-Bonferroni correction=.003), as well as rs117806152 (Additive model: P-Bonferroni (correction)=.05; dominant model: P-Bonferroni correction=.03). For TENM2, rs80003210 G allele contributed to the decreased risk of ATDILI (P-Bonferroni correction=.02), while rs2617972 A allele conferred susceptibility to ATDILI (P-Bonferroni correction=.01). Regarding rs2617972, significant findings were also observed in both additive (OR=3.203, 95% CI: 1.487-6.896, P-Bonferroni correction=.02) and dominant model (P-Bonferroni correction=.02). Moreover, rs79280755 and rs117806152 in BDKRB2 significantly affected some laboratory indicators. However, no meaningful SNPs were observed in TGFB2 and SLC2A13. Our study revealed that both BDKRB2 and TENM2 genetic polymorphisms were interrogated in relation to ATDILI susceptibility and some laboratory indicators in the Western Chinese Han population, shedding a new light on exploring novel biomarkers and targets for ATDILI.

Do genetic polymorphisms of B-cell CLL/lymphoma 2 confer susceptibility to anti-tuberculous therapy-associated drug-induced liver injury?

The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.

The Association Between HLA-DQB1 Polymorphism and Antituberculosis Drug-Induced Liver Injury: a Case-Control Study.

The Influence of B and T Lymphocyte Attenuator Genetic Variants on Susceptibility to Chronic Hepatitis B Virus Infection

Role of Polymorphic Bile Salt Export Pump (BSEP, ABCB11) Transporters in Anti-Tuberculosis Drug-Induced Liver Injury in a Chinese Cohort

Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment

Association between BCL-2 (-938C>A) polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated patients with advanced non-small cell lung cancer

TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults

The Variant at TGFBRAP1 but Not TGFBR2 is Associated with Antituberculosis Drug-Induced Liver Injury

Association of ABCC Gene Polymorphism with Susceptibility to Antituberculosis Drug–Induced Hepatotoxicity in Western Han Patients with Tuberculosis

Meta-analysis on relationship between polymorphisms of CYP2E1 gene and susceptibility to antituberculosis druginduced liver injury

Genetic Polymorphisms of Delta-Like 1 Homolog Influence the Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity.

Lack of association between genetic polymorphisms of CYP3A4, CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population.

Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Tuberculosis: A Meta-Analysis

Association of CYP2B6 Gene Polymorphisms and Anti-Tuberculosis Drug-Induced Hepatotoxicity in a Chinese Population.

Drug-metabolising Enzyme Polymorphisms and Predisposition to Anti-Tuberculosis Drug-Induced Liver Injury: a Meta-Analysis.

Prospective Study Of Aldh1a1 Gene Polymorphisms Associated With Antituberculosis Drug-Induced Liver Injury In Western Chinese Han Population

Polymorphism of the Interferon-Gamma Gene and Risk of Tuberculosis in a Southeastern Chinese Population.

CYP7A1, BAAT and UGT1A1 Polymorphisms and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity.

P5-19-07: the Effects of ABCC2 and SLCO1B3 Single Nucleotide Polymorphisms on Docetaxel-Induced Leukopenia in Breast Cancer Patients.

Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.